www.indivior.com Open in urlscan Pro
2a02:e980:d2::6a  Public Scan

Submitted URL: http://indivior.com/
Effective URL: https://www.indivior.com/en
Submission: On December 28 via manual from US — Scanned from DE

Form analysis 1 forms found in the DOM

GET /search

<form id="search-form" method="get" action="/search" role="search" class="search-form">
  <div>
    <fieldset>
      <label for="query">Search this site</label>
      <input type="hidden" name="lang" id="lang" value="en">
      <input type="text" name="q" id="query" placeholder="Search here…" role="searchbox">
      <button type="submit" aria-label="Search">Submit</button>
    </fieldset>
    <button type="button" aria-label="Cancel">Cancel</button>
  </div>
</form>

Text Content

OUR USE OF COOKIES

We use cookies so that we can improve the experience for visitors to our
websites. This includes cookies that are necessary for the operation of our
websites, as well as other cookies used for analytics purposes. We will not use
analytical cookies unless you enable them.

For more information about our use of cookies, please refer to our cookie
policy.

--------------------------------------------------------------------------------


ANALYTICS COOKIES

These cookies allow us to understand how our websites are used, and to improve
our websites over time.

Enable analytics cookies:

--------------------------------------------------------------------------------

Save and close

 * Skip to main content
 * Skip to search
 * Skip to navigation
 * Skip to footer

 * 
 * Product Query and Adverse Event
 * International
 * Search
 * Menu

Close


INTERNATIONAL WEBSITES

 * International
 * Australia (English)
 * Canada (English)
 * Canada (French)
 * Denmark (Danish)
 * Finland (Finnish)
 * France (French)
 * Germany (German)
 * Israel (Hebrew)
 * Italy (Italian)
 * Norway (Norwegian)
 * Sweden (Swedish)
 * UK (English)

Search this site Submit Cancel
 * About Us
   
   
   * ABOUT US
   
   * Our Approach
   * Our Leadership
   * Corporate Governance
     * Compliance With UK Governance Code
     * Committees
     * Global Conduct Policies
     * Internal Financial Control And Risk Management
     * Tax Strategy
 * Our Science
   
   
   * OUR SCIENCE
   
   * Therapeutic Focus Areas
   * Pipeline
   * Research and Development Publications
   * Externally Sponsored Studies and Independent Medical Education Grants
   * Indivior Charitable Contributions, Corporate Membership, and Corporate
     Collaborations
 * Products
 * Responsibility
   
   
   * RESPONSIBILITY
   
   * Approach
   * Environment & Climate Change
   * Workforce
   * Patient Safety & Product Quality
   * Corporate Integrity Agreement
   * Integrity & Compliance
     * Transparency Program
     * US Healthcare Providers
   * Business Conduct
   * Advocacy & Stakeholder Engagement
   * Sustainability Report
 * Investors
   
   
   * INVESTORS
   
   * Share Price & Tools
   * Results, Reports & Presentations
   * Alert Service
   * Financial Calendar
   * RNS filings
   * Shareholder Information
     * Dividends
     * Shareholder Meetings
     * ADR Information
     * Managing your shares
     * Demerger base cost
     * Prospectus
     * Share Repurchase Program
   * Contact Us (IR and Media)
   * Additional US Listing
   * Capital Markets Day
 * Our People
   
   
   * OUR PEOPLE
   
   * Careers
   * Locations
   * Working at Indivior
   * Our Guiding Principles
 * Media
   
   
   * MEDIA
   
   * Press Releases
   * Company Statements
   * Media Kit


PATIENT NEEDS INSPIRE US

Indivior is working to change patients' lives by developing medicines to treat
substance use disorders and serious mental illnesses.

About Us


OUR 2021 SUSTAINABILITY REPORT

Learn more about the steps we are taking to minimize our environmental impact,
reach our goals for diversity and inclusion and lead on social impact through
our mission to help patients.

Find out more about the report


LATEST NEWS

December 7 2022

Indivior Capital Markets Day Highlights Strategy for Shareholder Value Creation
and Attractive Medium-Term Profitable Growth Outlook

Read more


LATEST RESULTS

December 7 2022

Indivior 2022 Capital Markets Day

Read more


SHARE PRICE




CAREERS

Accelerate your career by making a difference

Read more


OUR R&D ACTIVITIES

Driving development in addressing addiction and behavioural health issues

Read more


NEWS AND MEDIA

The latest information on Indivior

Read more

 *  * About Us
    * Investors
    * Media
   
    * Therapeutic Focus Areas
    * Responsibility
    * Careers
   
    * Our Approach
    * People
    * Contact Us
   
    * Locations


 * USEFUL LINKS
   
    * Product Query or Adverse Event
    * Modern Slavery Statement
    * Sitemap
   
    * Terms of Use
    * Privacy Policy
    * Accessibility
   
    * Privacy Policy and Notice for California Residents
    * Privacy Notice Healthcare Professionals
    * Cookie Policy


 * FOLLOW US
   
    * LinkedIn

© 2022 Indivior PLC | This site is intended for US audiences | INDIVIOR is a
registered trademark of Indivior UK Limited | Imagery for illustrative purposes
only.